Operation Warp Speed

Category

Pharm-Olam Selected as a CRO for Department of Defense Support to Operation Warp Speed Vaccine Trials, Partnering with Geneva Foundation

Pharm-Olam, a global mid-sized clinical research organization (CRO), has been selected by the U.S. Department of Defense (DOD) to build capability at military treatment facilities in order to support Phase III clinical trials of one or more lead COVID-19 vaccine...

Big Money, Politics & Fed Gov Redirects & Captivates Mass Attention: Obscuring Pragmatic Off-Label Studies Targeting COVID-19

COVID-19 therapeutic clinical trials involving off-label, generics and those sponsored by small biotech generally continue to experience delays due to lack of awareness during the political season, consolidation of federal research power during the pandemic as well as...

NC-Based Velocity Clinical Research Selected for All Five Major Vaccine Research Programs Nationwide

Durham-based Velocity Clinical Research (Velocity Clinical) continues executing on its goal of expanding the company’s national base of research sites while transforming the research sector from one of many fragmented small sites and at times non-responsive networks...

U.S. Placing its Bets on COVID-19 Vaccines Rather than Treatments

Earlier this month, the Biomedical Advanced Research and Development Authority, or BARDA, part of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS), apparently notified companies and researchers that...

Pin It on Pinterest